AUSCANN GROUP HOLDINGS LIMITED (AC8)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
AC8 - AUSCANN GROUP HOLDINGS LIMITED
FNArena Sector :
NONE
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: N/A
Index:
FNArena Sector : NONE
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: N/A
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$0.04
07 May |
0.000 OPEN $0.04 |
0.000 HIGH $0.04 |
0 LOW $0.04 |
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | -2.5 |
DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | - |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 1.6 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -3.3 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | - |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -84.47 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -84.47 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | -83.01 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | -84.47 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | -92.42 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -3.3 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | - |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | - |
Total Debt | xxx | xxx | xxx | xxx | xxx | - |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 7 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 2.45 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | - |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | - |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 0 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 12 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | 0 M |
Investments - Total | xxx | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
0.0
No. Of Recommendations
0
AC8 STOCK CHART
FNArena News on AC8
1 |
Spotlight On ASX-Listed Cannabis CompaniesJan 31 2024 - Small Caps |
2 |
Paw Patrol; Investing In Non-Discretionary PetsAug 28 2023 - Small Caps |
3 |
Mainstreaming Marijuana: Not What You’d ExpectSep 28 2020 - Weekly Reports |
4 |
Risks Of Investing In Medical CannabisJun 07 2017 - FYI |
5 |
Investor Optimism Keeps The Bull AliveMar 29 2017 - Rudi's View |